Gabapentin & Pregabalin – to be Controlled Drugs in 2019

The Home Office has announced plans to classify both gabapentin and pregabalin as Class C controlled drugs in April 2019.

The decision to apply Misuse of Drugs act controls to gabapentin and pregabalin is based on advice from the Advisory Council on the Misuse of Drugs – in response to concerns over medicinal misuse, illegal diversion of the drugs and addiction – and the results of a public consultation.